Related Articles by Review for PMID: 16630937

Year	Number of Results
1982	1
1985	1
1987	2
1989	1
1991	2
1992	2
1993	2
1994	1
1995	1
1996	1
1997	3
1998	5
1999	1
2000	7
2001	1
2002	2
2003	13
2004	12
2005	15
2006	8
2007	6
2008	7
2009	16
2010	15
2011	21
2012	13
2013	16
2014	25
2015	20
2016	20
2017	15
2018	13
2019	5
2020	3
2021	4
2022	5
2023	3
2024	3

1

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Durham SR, et al. J Allergy Clin Immunol. 2006 Apr;117(4):802-9. doi: 10.1016/j.jaci.2005.12.1358. J Allergy Clin Immunol. 2006. PMID: 16630937 Clinical Trial.

2

Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet.

Nelson H, Lehmann L, Blaiss MS. Nelson H, et al. Curr Med Res Opin. 2012 Jun;28(6):1043-51. doi: 10.1185/03007995.2012.684676. Epub 2012 May 9. Curr Med Res Opin. 2012. PMID: 22502864 Review.

3

Oralair(®): a causal treatment for grass pollen-induced allergic rhinoconjunctivitis.

Köberlein J, Mösges R. Köberlein J, et al. Immunotherapy. 2013 Jan;5(1):13-21. doi: 10.2217/imt.12.147. Immunotherapy. 2013. PMID: 23256794 Review.

4

300IR 5-Grass pollen sublingual tablet offers relief from nasal symptoms in patients with allergic rhinitis.

Serrano E, Wahn HU, Didier A, Bachert C. Serrano E, et al. Am J Rhinol Allergy. 2014 Nov-Dec;28(6):471-6. doi: 10.2500/ajra.2014.28.4112. Epub 2014 Oct 20. Am J Rhinol Allergy. 2014. PMID: 25335122 Review.

5

[Preventive immunotherapy].

Boquete M, Carballada F, Expósito F, González A. Boquete M, et al. Allergol Immunopathol (Madr). 2000 May-Jun;28(3):89-93. Allergol Immunopathol (Madr). 2000. PMID: 10867376 Review. Spanish.

6

Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy.

Nelson H, Cartier S, Allen-Ramey F, Lawton S, Calderon MA. Nelson H, et al. J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):256-266.e3. doi: 10.1016/j.jaip.2014.09.018. Epub 2014 Nov 20. J Allergy Clin Immunol Pract. 2015. PMID: 25609326 Review.

7

Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience.

Didier A, Wahn U, Horak F, Cox LS. Didier A, et al. Expert Rev Clin Immunol. 2014 Oct;10(10):1309-24. doi: 10.1586/1744666X.2014.957677. Epub 2014 Sep 10. Expert Rev Clin Immunol. 2014. PMID: 25205329 Review.

8

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis.

Devillier P, Dreyfus JF, Demoly P, Calderón MA. Devillier P, et al. BMC Med. 2014 May 1;12:71. doi: 10.1186/1741-7015-12-71. BMC Med. 2014. PMID: 24885894 Free PMC article. Review.

9

An extract of Timothy-grass pollen used as sublingual immunotherapy for summer hay fever.

Kay AB. Kay AB. Drugs Today (Barc). 2007 Dec;43(12):841-8. doi: 10.1358/dot.2007.43.12.1162079. Drugs Today (Barc). 2007. PMID: 18174969 Review.

10

Specific immunotherapy for allergic rhinitis to grass and tree pollens in daily medical practice-symptom load with sublingual immunotherapy compared to subcutaneous immunotherapy.

Sieber J, Shah-Hosseini K, Mösges R. Sieber J, et al. Ann Med. 2011;43(6):418-24. doi: 10.3109/07853890.2011.595426. Epub 2011 Jun 17. Ann Med. 2011. PMID: 21679103 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

273 results

Results by year